Navigation Links
Lupin is Granted USFDA Approval for Levetiracetam Tablets
Date:1/16/2009

BALTIMORE, Jan. 16 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval for the Company's Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750mg and 1000mg from the U.S. Food and Drug Administration (USFDA). Commercial shipments of the product have commenced.

Lupin's Levetiracetam tablets are the AB-rated generic equivalent of UCB Pharmaceuticals' Keppra(R) tablets, indicated as adjunctive therapy in the treatment of certain types of seizures associated with epilepsy. Keppra tablets had annual sales of approximately $1.2 billion (USD) for the twelve months ended September 2008, based on IMS Health sales data.

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs.

The Company's R&D endeavors have resulted in significant progress in its NCE program. The Company's foray into New Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.

For the financial year ended March 2008, the Lupin's Revenues and Profit after Tax were Rs.27,730 million (US$ 694 million) and Rs.4,083 million (US$ 102 million) respectively. Please visit http://www.lupinworld.com for more information about Lupin Ltd.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six Pharmaceutical companies in India. Th
'/>"/>

SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Lupin Receives USFDA Approval for Topiramate Tablets
2. Lupin Launches Ramipril Capsules
3. Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
4. Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for Suprax(R) 400 mg Tablets in the U.S.
5. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
6. Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians
7. Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
8. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
9. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
10. USC granted $8.4 million for autism research
11. Aida Granted Additional Anti-Cancer Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Dr. ... and Distinguished Teaching Professor of the Department of Plastic ... other doctors to review reports of blindness resulting from ... surgery . The group published their study, along with ... Reconstructive Surgery journal. , "We began to see increasing ...
(Date:4/1/2015)... Texas (PRWEB) April 01, 2015 Senior ... Best of Home Care Provider of Choice Award by Home ... Choice Award is given to home care providers who ... providers are best-in-class for quality in home care. This recognition ... your satisfaction and will provide you with quality, trustworthy in ...
(Date:4/1/2015)... Wayne, PA (PRWEB) April 01, 2015 ... critical points in the talent lifecycle, and the premiere ... Hiring Expert Series will feature a webinar on “Using ... presented by the chief human resources officer of MorseLife, ... support services for seniors and their families in Palm ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 The U.S. ... are “more than 123,000 patients who are waiting for ... aware of this surprising statistic. , In ... PSA, Erik Compton, a PGA TOUR golfer and two-time ... encourages Americans to become organ donors. He inspires ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Nike Tennis ... for boys and girls ages 10-17, providing campers with ... athletes. Players will experience all 4 Grand Slam surfaces ... centre, home of Great Britain’s Davis Cup team and ... edge of Richmond Park, the National Tennis Centre is ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2
... , This release is available in German ... Foundation) will establish 21 new Collaborative Research Centres (CRCs) as ... Grants Committee at its spring meeting in Bonn. The new ... euros (including a 20 percent programme allowance for indirect project ...
... of the appendix and tonsils before the age of ... heart attack in a large population study performed in ... 1.44) and appendectomy by 33% (HR 1.33). The risk ... when the tonsils and appendix were both removed. However, ...
... (RBMs) which provide prior authorization for imaging services ... costs to physicians and have the potential to either ... in the June issue of the Journal of ... RBMs are widely used by private payers ...
... tailored for each patient extends disease-free survival by 14 months, ... a specific biological marker, a team led by scientists at ... in the online version of Journal of Clinical Oncology. ... the usual time until relapse for follicular lymphoma by about ...
... Reporter , TUESDAY, May 31 (HealthDay News) -- A ... "biomarkers" with certain diseases has vastly overrated the connections, ... frequently cited studies published between 1991 and 2006 in ... than half of the biomarkers studied revealed statistically significant ...
... Ohio New research proves that a change in a ... of brain cancer will respond better to treatment. Testing for ... form of glioblastoma, the most common and an often-fatal type ... say. The prospective study looked at a gene called MGMT ...
Cached Medicine News:Health News:DFG to establish 21 new collaborative research centers 2Health News:DFG to establish 21 new collaborative research centers 3Health News:DFG to establish 21 new collaborative research centers 4Health News:DFG to establish 21 new collaborative research centers 5Health News:DFG to establish 21 new collaborative research centers 6Health News:DFG to establish 21 new collaborative research centers 7Health News:DFG to establish 21 new collaborative research centers 8Health News:DFG to establish 21 new collaborative research centers 9Health News:Surgical removal of the tonsils and appendix associated with risk of early heart attack 2Health News:Surgical removal of the tonsils and appendix associated with risk of early heart attack 3Health News:Radiology benefit managers adversely affect referring physicians, study suggests 2Health News:Vaccine increases disease-free survival for follicular lymphoma patients 2Health News:Vaccine increases disease-free survival for follicular lymphoma patients 3Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 3Health News:Gene change identifies brain cancer patients that respond better to treatment 2
(Date:4/1/2015)... 1, 2015 LifeScienceIndustryResearch.com ... Azithromycin Industry and 2015 Deep Research Report ... to Pharmaceutical category in its database.  ... Azithromycin basic information, including definition, classification, application, ... and news analysis, etc. Azithromycin Key Manufacturers ...
(Date:4/1/2015)... , April 1, 2015 In what is ... and NAMSA -the leading global medical research organization -- are co-organizing ... will be held April 19-20 during the MEDTEC China South ... of the event is to assist Chinese medical device manufacturers ... that NAMSA will convene this conference in China ...
(Date:4/1/2015)... -- Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the ... chairman and executive director purchased 40,000,000 ordinary shares (the ... entire issued share capital of the Company from AMG ... amount of approximately HK$113 million. Upon the completion of ... 45.17% to 47.17%. Mr. Jin Dongtao, ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5MEDTEC & NAMSA Co-organize BPMDS Symposium China 2MEDTEC & NAMSA Co-organize BPMDS Symposium China 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5
... , , MINNEAPOLIS, Jan. 11 ATS Medical, Inc. ... surgery products and services today announced preliminary fourth quarter 2009 ... by ATS Medical,s President and Chief Executive Officer, Michael Dale, ... January 13, 2010, in San Francisco, CA, at 8 a.m. ...
... , , PRINCETON, N.J., Jan. 11 PharmaNet Development ... to innovative pharmaceutical, biotechnology, generic drug and medical device ... a complementary symposium and round table discussion entitled "Crossing ... , Recently, the Company successfully hosted a similar symposium ...
Cached Medicine Technology:ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to Clinical Studies' to be Held February 2010 in Basel, Dusseldorf and Vienna 2PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to Clinical Studies' to be Held February 2010 in Basel, Dusseldorf and Vienna 3
Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
... medication administration, any error is one you ... is the Dynamic Hospital AdministratOR. This powerful ... system, suitable for hospitals of all sizes. ... or as a fully-integrated component of existing ...
... the AutoPPI barcoded wristband, manages the delivery ... patient. The system ensures that the drug ... and provides printed medication delivery receipts for ... record of the caregiver, location and time ...
... Positive patient identification ... patient safety. Olympus osYris ... barcoded wristband system to ... reliably and consistently reducing ...
Medicine Products: